These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3544514)

  • 41. Drug treatment of hyperprolactinemia.
    Chanson P; Borson-Chazot F; Chabre O; Estour B
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):113-7. PubMed ID: 17532288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical course and the effectiveness of conservative treatment of prolactin-secreting pituitary adenoma].
    Sabakhtarashvili MA; Veĭnberg EG; Kurashvili RB; Kanchaveli ZSh
    Akush Ginekol (Mosk); 1989 Oct; (10):50-4. PubMed ID: 2618957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Idiopathic granulomatous mastitis associated with hyperprolactinemia: A nonoperative approach.
    Li J; McGregor HP
    Breast J; 2017 Nov; 23(6):742-744. PubMed ID: 28845595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hyperprolactinemia as a cause of endocrine-induced sterility].
    Rachen E; Spasov S
    Akush Ginekol (Sofiia); 1985; 24(5):76-80. PubMed ID: 3911787
    [No Abstract]   [Full Text] [Related]  

  • 45. Herbal medicine (Shakuyaku-kanzo-to) improves olanzapine-associated hyperprolactinemia: a case report.
    Hori H; Yoshimura R; Katsuki A; Nakamura J
    J Clin Psychopharmacol; 2013 Feb; 33(1):122-3. PubMed ID: 23288231
    [No Abstract]   [Full Text] [Related]  

  • 46. [Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia].
    Veglio F; Pinna G; Rabbia F; Mulatero P; Chiandussi L
    Minerva Endocrinol; 1992; 17(1):43-6. PubMed ID: 1323053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica.
    Canales ES; Cano C; Ablanedo J; Zárate A
    Horm Res; 1981; 15(4):213-7. PubMed ID: 6927819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guidelines for the diagnosis and treatment of hyperprolactinemia.
    Biller BM; Luciano A; Crosignani PG; Molitch M; Olive D; Rebar R; Sanfilippo J; Webster J; Zacur H
    J Reprod Med; 1999 Dec; 44(12 Suppl):1075-84. PubMed ID: 10649814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
    Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
    J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Follow-up of the effect of prolactin-lowering substances].
    Gazárek F; Talas M; Stehlíková J; Zenísek L; Fingerová H
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():102-9. PubMed ID: 6242680
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prolactin and TSH response in functional tests in patients with primary hypothyroidism in a context of hyperprolactinemia].
    Chernova TO; Kolesnikova GS; Mudretsova SV; Serpukhovitin SIu; Goncharov NP; Gereasimov GA
    Probl Endokrinol (Mosk); 1994; 40(5):16-8. PubMed ID: 7899431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hyperprolactinemia in malignant lymphomas].
    Grobe N; Rühle H; Eckelmann G
    Dtsch Med Wochenschr; 1990 Nov; 115(48):1825-7. PubMed ID: 2245764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prolactin and the laboratory].
    Veloza A; Prazeres S
    Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and management of hyperprolactinemia.
    Dluhy RG
    Compr Ther; 1988 Sep; 14(9):9-15. PubMed ID: 3064964
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical presentation of hyperprolactinemia.
    Luciano AA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperprolactinemia diagnostics--dilemmas over optimal selection of prolactinemia time points.
    Szosland K; Stasiak M; Lewiński A
    Ann Agric Environ Med; 2015; 22(2):332-7. PubMed ID: 26094534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of hyperprolactinemia on prolactin and LH pulsatile pattern in female rats.
    Lafuente A; Marcó J; Esquifino AI
    Rev Esp Fisiol; 1992 Dec; 48(4):291-6. PubMed ID: 1302899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prolactin-secreting tumor in a patient with Klinefelter's syndrome: a case report.
    Pinto AC; Czepielewski MA; Gross JL; Mussio W; Lengyel AM
    J Endocrinol Invest; 1996 Apr; 19(4):248-52. PubMed ID: 8862506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences.
    Voicu V; Medvedovici A; Ranetti AE; Rădulescu FŞ
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):955-68. PubMed ID: 23600946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.